Become a Member DC Helpdesk Member Sign In

ARA Signed a Letter to FDA on Plant Gene Editing

Jul 29 2020

On July 29, ARA signed a letter to the Food & Drug Administration (FDA) Commissioner Stephen Hahn calling for clarifying guidance for plants derived from gene-editing and advanced plant breeding methods.

ARA and the undersigned organizations urge FDA to publish this draft guidance as soon as possible "to minimize the risks of these innovation-stifling outcomes and to continue to advance the position of the United States as the global leader in biotechnology development.

Read the letter to learn more.

Read letter